Roberts David B 4

What Happened

• David B. Roberts, President and Director of LEMAITRE VASCULAR, was credited with a total of 21.371 dividend-equivalent rights (derivative awards) on 2026-06-04. The Form 4 shows nine separate accruals (see list below). Each item was reported as an award/acquisition (code A) at a $0.00 per-share price, so no cash was paid and the reported value is $0 on the Form 4. These are not open-market purchases or sales; they are dividend equivalents that vest with underlying restricted stock units (RSUs) or performance share units (PSUs).

Key Details

• Transaction date: 2026-06-04; Form filed: 2026-06-05 (appears timely).
• Items credited (share equivalents and footnote references):
  • 1.824 (F1), 1.824 (F2), 3.117 (F3), 3.734 (F4), 2.708 (F5), 3.068 (F6), 0.262 (F7), 0.297 (F8), 4.537 (F9) — total 21.371.
• Price reported: $0.00 per unit; reported total value on form: $0 (these are dividend-equivalent rights, not cash purchases).
• Nature of instrument: derivative dividend-equivalent rights that are the economic equivalent of one share and vest proportionately with the underlying RSU/PSU awards.
• Shares owned after the transaction: not specified in the provided extract — see the full Form 4 for total holdings and ownership percentage.
• No 10b5-1, tax-withholding, or late-filing flags noted in the provided summary.

Context

• Dividend-equivalent rights are credits tied to existing RSU/PSU awards; they accrue like dividends and convert to shares (or cash) only as the underlying awards vest. They are compensation-related and do not indicate an open-market buy or sell by the insider.
• For retail investors: awards and dividend equivalents are routine executive compensation. They are informative about compensation accrual but do not necessarily signal insider sentiment about the stock.